Mycoplasmas - Stealth Pathogens
By Leslie Taylor January, 2001
Mycoplasmas are a specific and unique species of bacteria - the smallest free-living organism known on the planet.
The primary differences between mycoplasmas and other bacteria is that bacteria have a solid cell-wall structure
and they can grow in the simplest culture media. Mycoplasmas however, do not have a cell wall, and like a tiny
jellyfish with a pliable membrane, can take on many different shapes which make them difficult to identify, even
under a high powered electron microscope. Mycoplasmas can also be very hard to culture in the laboratory and
are often missed as pathogenic causes of diseases for this reason.
The accepted name was chosen because Mycoplasmas were observed to have a fungi-like structure (Mycology is
the study of fungi - hence "Myco") and it also had a flowing plasma-like structure without a cell wall - hence
"plasma". The first strains were isolated from cattle with arthritis and pleuro-pneumonia in 1898 at the Pasteur
Institute. The first human strain was isolated in 1932 from an abscessed wound. The first connection between
mycoplasmas and rheumatoid diseases was made in 1939 by Drs. Swift and Brown. Unfortunately, mycoplasmas
didn't become part of the medical school curriculum until the late 1950's when one specific strain was identified
and proven to be the cause of atypical pneumonia, and named Mycoplasma pneumonia. The association between
immunodeficiency and autoimmune disorders with mycoplasmas was first reported in the mid 1970s in patients
with primary hypogammaglobulinemia (an autoimmune disease) and infection with four species of mycoplasma
that had localized in joint tissue. Since that time, scientific testing methodologies have made critical technological
progress and along with it, more mycoplasma species have been identified and recorded in animals, humans and
While Mycoplasma pneumonia is certainly not the only species causing disease in humans, it makes for a good
example of how this stealth pathogen can move out of it's typical environment and into other parts of the body and
begin causing other diseases. While residing in the respiratory tract and lungs, Mycoplasma pneumonia remains an
important cause of pneumonia and other airway disorders, such as tracheobronchitis, pharyngitis and asthma.
When this stealth pathogen hitches a ride to other parts of the body, it is associated with non-pulmonary
manifestations, such as blood, skin, joint, central nervous system, liver, pancreas, and cardiovascular syndromes
and disorders. Even as far back as 1983, doctors at Yale noted:
"Over the past 20 years the annual number of reports on extrapulmonary symptoms during Mycoplasma
(M.) pneumoniae disease has increased. Clinical and epidemiological data indicate that symptoms from
the skin and mucous membranes, from the central nervous system, from the heart, and perhaps from other
organs as well are not quite uncommon manifestations of M. pneumoniae disease."(15)
This single stealth pathogen has been discovered in the urogenital tract of patients suffering from inflammatory
pelvic disease, urethritis, and other urinary tract diseases (8) It has been discovered in the heart tissues and fluid
of patients suffering from cardititis, pericarditis, tachycardia, hemolytic anemia, and other coronary heart
diseases.(9, 10, 14) It has been found in the cerebrospinal fluid of patients with meningitis and encephalitis, seizures,
ALS, Alzheimer's and other central nervous system infections, diseases and disorders.(11-13) It has even been found
regularly in the bone marrow of children with leukemia.(16- 18) It is amazing that one single tiny bacteria can be
the cause of so many seemingly unrelated diseases in humans. But as with all mycoplasma species, the disease is
directly related to where the mycoplasma resides in the body and which cells in the body it attaches to or invades.
Today, over 100 documented species of mycoplasmas have been recorded to cause various diseases in humans,
animals, and plants. Mycoplasma pneumonia as well as at least 7 other mycoplasma species have now been linked
as a direct cause or significant co-factor to many chronic diseases including, rheumatoid arthritis, Alzheimer's,
multiple sclerosis, fibromyalgia, chronic fatigue, diabetes, Crohn's Disease, ALS, nongonoccal urethritis, asthma,
lupus, infertility, AIDS and certain cancers and leukemia, just to name a few.(1-6) In 1997, the National Center for
Infectious Diseases, Centers for Disease Control and Prevention's journal, Emerging Infectious Diseases, published
the article, Mycoplasmas: Sophisticated, Reemerging, and Burdened by Their Notoriety, by Drs. Baseman and
Tully who stated:
"Nonetheless, mycoplasmas by themselves can cause acute and
chronic diseases at multiple sites with wide-ranging complications and have been implicated as cofactors in disease. Recently, mycoplasmas
have been linked as a cofactor to AIDS pathogenesis and to malignant
transformation, chromosomal aberrations, the Gulf War Syndrome,
and other unexplained and complex illnesses, including chronic fatigue
syndrome, Crohn's disease, and various arthritides."
Mycoplasmas, unlike viruses, can grow in tissue fluids (blood, joint, heart, chest and spinal fluids) and can grow
inside any living tissue cell without killing the cells, as most normal bacteria and viruses will do. Mycoplasmas
are frequently found in the oral and genito-urinary tracts of normal healthy people and are found to infect females
four times more often than males, which just happens to be the same incidence rate in rheumatoid arthritis,
fibromyalgia, Chronic Fatigue and other related disorders.(7) Mycoplasmas are parasitic in nature and can attach
to specific cells without killing the cells and thus their infection process and progress can go undetected. In some
people the attachment of mycoplasmas to the host cell acts like a living thorn; a persistent foreign substance,
causing the host's immune defense mechanism to wage war. This allergic type of inflammation often results in
heated, swollen, and painful inflamed tissues, like those found in rheumatoid diseases, fibromyalgia and many
other autoimmune disorders like lupus and MS, Crohn's and others. In such cases the immune system begins
attacking itself and/or seemingly healthy cells. Some species of mycoplasmas also have the unique ability to
completely evade the immune system. Once they attach to a host cell in the body, their unique plasma and protein
coating can then mimic the cell wall of the host cell and the immune system cannot differentiate the mycoplasma
from the body's own host cell.
Mycoplasmas are parasitic in nature because they rely on the nutrients found in host cells including cholesterol,
amino acids, fatty acids and even DNA. They especially thrive in cholesterol rich and arginine-rich environments.
Mycoplasmas can generally be found in the mucous membrane in the respiratory tract. They need cholesterol for
membrane function and growth, and there is an abundance of cholesterol in the bronchial tubes of the respiratory
tract. Once attached to a host cell, they then begin competing for nutrients inside the host cells. As nutrients are
depleted, then these host cells can begin to malfunction, or even change normal functioning of the cell, causing
a chain reaction with other cells (especially within the immune and endocrine systems). Mycoplasmas can even
cause RNA and DNA mutation of the host cells and have been linked to certain cancers for this reason.
Mycoplasmas can also invade and live inside host cells which evade the immune system, especially white blood
cells. Once inside a white blood cell, mycoplasmas can travel throughout the body and even cross the blood/brain
barrier, and into the central nervous system and spinal fluid.
More research here
- Baseman, Joel, et.al., Mycoplasmas: Sophisticated, Reemerging, and Burdened by Their Notoriety, CDC, Journal of Infectious
Diseases, Vol 3, No.1, Feb 1997
- S-C. Mycoplasmas and AIDS. In: Maniloff J, McElhaney RN, Finch LR, Baseman JB, editors. Mycoplasmas: molecular biology and
pathogenesis. Washington (DC): American Society for Microbiology, 1992:525-45.
- Nicolson G, Nicolson NL. Diagnosis and treatment of mycoplasmal infections in Gulf War illness-CFIDS patients. Intl J Occup Med
Immunol Toxicol 1996;5:69-78.
- Wear DJ, et.al. Mycoplasmas and oncogenesis:persistent infection and multistage malignant transformation.
Proc Natl Acad Sci USA 1995;92:10197-201.
- Ekbom A, Daszak P, Kraaz W, Wakefield AJ. Crohn's disease after in-utero measles virus exposure. Lancet 1996;348:516-7.
- Taylor-Robinson D. Mycoplasmas in rheumatoid arthritis and other human arthritides. J Clin Pathol 1996;49:781-2.
- Dr.Harold Clark, The Intercessor, June 1993, The Road Back Foundation, Delaware OH.
- Goulet M, et.al., Isolation of Mycoplasma pneumoniae from the human urogenital tract. J Clin Microbiol 1995;33:2823-5
- Daxbock F, et.al., Severe hemolytic anemia and excessive leukocytosis masking mycoplasma pneumonia. Ann Hematol. 2001
- Higuchi ML, et.al., Detection of Mycoplasma pneumoniae and Chlamydia pneumoniae in ruptured atherosclerotic plaques. Braz
J Med Biol Res. 2000 Sep;33(9):1023-6.
- Socan M, Neurological symptoms in patients whose cerebrospinal fluid is culture- and/or polymerase chain reaction-positive for
Mycoplasma pneumoniae. Clin Infect Dis. 2001 Jan 15;32(2):E31-5.
- Bencina D, et.al., Intrathecal synthesis of specific antibodies in patients with invasion of the central nervous system by Mycoplasma
pneumoniae. Eur J Clin Microbiol Infect Dis. 2000 Jul;19(7):521-30
- Smith R, et.al., Neurologic manifestations of Mycoplasma pneumoniae infections: diverse spectrum of diseases. A report of six
cases and review of the literature. Clin Pediatr (Phila). 2000 Apr;39(4):195-201.
- Umemoto M, Advanced atrioventricular block associated with atrial tachycardia caused by Mycoplasma pneumoniae infection.
Acta Paediatr Jpn. 1995 Aug;37(4):518-20.
- Lind K. Manifestations and complications of Mycoplasma pneumoniae disease: a review.Yale J Biol Med. 1983
- Alexander FE. Is Mycoplasma Pneumonia associated with childhood acute lymphoblastic leukemia? Cancer Causes Control.
- Hall JE, Mycoplasma pneumonia in acute childhood leukemia. Pediatr Pulmonol. 1985 Nov-Dec;1(6):333-6.
- Murphy WH, Gullis C, Dabich L, Heyn R, Zarafonetis CJD. Isolation of Mycoplasma from leukemic and nonleukemia patients. J Nat Cancer Inst 1970;45:243-51.
To understand how mycoplasmas can cause widespread disease, we must first look at the species' unique properties
and interactions with host cells. Unlike viruses and bacteria, mycoplasmas are the smallest free-living and
self-duplicating microorganisms, as they don't require living cells to replicate their DNA and growth.
HOW MYCOPLASMAS INTERACT IN THE BODY
- Mycoplasmas are able to hide inside the cells of the host (patient) or to attach to the outside of host cells.
- Whether they live inside or outside the host cell, they depend on host cells for nutrients such as cholesterol,
amino acids, etc. They compete with the host cells for these nutrients which can interfere with host cell
function without killing the host cell.
- A mycoplasma has very little DNA of its own, but is capable of using DNA from a host cell. When a
mycoplasma takes over the DNA of the host cell, anything can happen - including causing that cell to
malfunction in many different ways and/or die, or can cause DNA mutation of the host cell.
- Mycoplasmas attach to host cells with a tiny arm coated in protein which attaches to the protein coating of
host cells. For this reason, antibiotics like tetracycline, which are classified as "protein synthesis inhibitors"
are often used against mycoplasma infections. While these antibiotics may block this protein attachment and
very slowly starve it from the nutrients it needs from host cells to thrive and replicate, it still takes a healthy
immune system to actually kill the mycoplasma for good.
- Mycoplasmas are highly adaptable to changing environments and can move anywhere in the body, attaching
to or invading virtually any type of cell in the body.
- The mycoplasma adhesion proteins are very similar to human proteins. Once adhered to the host cell, the
mycoplasma can completely mimic or copy the protein cell of the host cell. This can cause the immune
system to begin attacking the body's own cells; an event that happens in all autoimmune diseases.
- Certain Mycoplasma species can either activate or suppress host immune systems, and they may use these
activities to evade host immune responses. Mycoplasmas can turn on the chain reaction called an immune
system response. This includes the stimulation of pro-inflammatory cytokines (chemical messengers of the
immune system) which is generally found in most autoimmune and inflammatory diseases and disorders.
- Mycoplasma can also attach to or invade immune system cells, like the very phagocytes (natural killer cells)
that are supposed to kill them. Inside these phagocytes, they can be carried to new locations of inflammation
or disease - hidden away like a spy who has infiltrated the defending army.
- When a mycoplasma attaches to a host cell, it generates and releases hydrogen peroxide and superoxide
radicals which cause oxidative stress and damage to the surrounding tissues.
||Arthritis, chronic nongonococcal urethritis, chronic pelvic inflammatory disease, other urogenital infections and diseases, infertility, AIDS/HIV
|| Arthritis, Gulf War Syndrome, Fibromyalgia, Chronic Fatigue Syndrome, Lupus,
AIDS/HIV, autoimmune diseases, ALS, psoriasis and Scleroderma, Crohn's and
IBS, cancer, endocrine disorders, Multiple Sclerosis, diabetes
|| Arthritis, TMJ disorders, Eye and ear disorders and infections, gingivitis,
periodontal diseases including even cavities.
|Mycoplasma hominis and Ureaplasma urealyticum
||Pelvic inflammatory disease, infertility, non-gonococcal urethritis, vaginitis, cervicitis, amnionitis, pyelonephritis,
post-partum septicemia, neonatal pneumonia, neonatal conjunctivitis, Reiter's syndrome, peritonitis, wound infections
(C-section), low birth weight infants, and premature rupture of membranes.
|| Pneumonia, asthma, upper and lower respiratory diseases, heart diseases, leukemia, Steven-Johnson
syndrome, polyarthritis or septic arthritis,
CNS disorders and diseases, urinary tract infections, Crohn's and Irritable Bowel Syndrome, Guillain-Barr
syndrome, polyradiculitis, encephalitis, and septic meningitis, autoimmune diseases.
| Mycoplasma incognitus and
|AIDS/HIV, urogenital infections and diseases, Autoimmune disorders and diseases
|| Urogenital infections and diseases, AIDS/HIV
|Mycoplasma faucium, M. lipophilum and M. buccale
|| Diseases of the
gingival crevices and respiratory tract
Follow this link for more technical information and clinical studies.
- Krause DC, Taylor-Robinson D. Mycoplasmas which infect humans. In: Maniloff J, McElhaney RN, Finch LR, Baseman JB, editors.
Mycoplasmas: molecular biology and pathogenesis. Washington (DC): American Society for Microbiology, 1992:417-44.
- Murray HW, Masur H, Senterfit LB, Roberts RB. The protean manifestations of Mycoplasma pneumoniae infection in adults. Am
J Med 1975;58:229-42.
- Baseman, Joel, et.al., Mycoplasmas: Sophisticated, Reemerging, and Burdened by Their Notoriety. CDC, Journal of Infectious
Diseases, Vol 3, No.1, Feb 1997
- Blanchard, A., et.al., AIDS-associated mycoplasmas. Ann.Rev.Microbiol. 1994; 48:687-712.
- Hawkins, et.al., Association of mycoplasma and human immunodeficiency virus infection: detection of amplified mycoplasma
fermentans DNA in blood. J.Infec.Dis. 1992: 165:581-585
- Hussain AI, et.al., Mycoplasma penetrans and other mycoplasmas in urine of human immunodeficiency virus-positive children.
J Clin Microbiol. 1999 May;37(5):1518-23.
Mycoplasmas and Fibromyalgia information here.
HSI Article on mycoplasma and autoimmune disorders here
The negative impact of a mycoplasmal infection on the human immune system is undisputed. Due to it's ability
to either activate or suppress the immune system, it is now being considered one of the culprits of many
autoimmune diseases. Yet, scientists still argue over the "chicken or egg first" type of sequence of events. Do the
mycoplasmas begin growing and replicating first and then weaken or deregulate the immune system? Or does a
weakened immune system (caused by stress, poor diet or other illness) allow the mycoplasmas to take hold and begin
their opportunistic growth resulting in chronic disease and to weaken and deregulate the immune
system even further? The answer is probably both, and it becomes one of the most critical treatment aspects of
mycoplasmal infections. In immunodeficient patients it can be very difficult to treat these mycoplasma infections
with appropriate broad spectrum antibiotics which are immunosuppressive themselves. Although the tetracycline
and erythromycin types of antibiotics are effective for some mycoplasmal infections, M. fermentans, M. hominis
and M. pirum strains are usually resistant to erythromycin, and tetracycline-resistant strains of M. hominis and U.
urealyticum have been reported. However, these antibiotics have a very limited ability to directly kill these
mycoplasmas, and their efficacy eventually depends on an intact host immune system to eliminate the
mycoplasmas. These types of protein inhibiting antibiotics will stop the protein adhesion of the mycoplasma to
host cells but won't directly kill the mycoplasma itself. With an already weaken immune system, many patients
lack the ability to mount a strong antibody response against these deadly stealth pathogens to kill them effectively.
Regardless, many physicians and rheumatologists are treating their arthritis, CFISD, fibromyalgia and other
mycoplasma infections with long term antibiotic therapy. One of the more popular conventional protocols
involves rotating multiple 6 week cycles of Minocycline or Doxycycline (200-300 mg/day), Ciprofloxacin (1,500
mg/day), Azithromycin (250-500 mg/day, and/or Clarithromycin (750-1,000 mg/day) among others.(1) Sometimes
the side effects of these strong antibiotics can be as bad as the symptoms of the diseases they are treating since a
minimum of 6 months and up to two years of antibiotic therapy may be required. Many doctors now believe that
antibiotics should not be used solely or exclusively to treat mycoplasmal infections, without addressing rebuilding
the immune system which is imperative for a complete recovery and eradication of infection. Others are using
more natural antibiotics found in plants which can be as effective or more effective with fewer side effects or
negative impact on the body. These include olive leaf extract products, urva ursi, and Neem leaf or seed extracts. Also see Raintree's Myco herbal formula.
One of the main side effects of antibiotics, whether it is a natural plant antibiotic or a chemical antibiotic, is the
loss of friendly bacteria that is needed in the gastrointestinal system for proper digestion and elimination. No
antibiotic can differentiate a friendly bacteria from a harmful one. Therefore, any time an antibiotic must be taken,
especially long term, taking a probiotic formula to replace friendly bacteria is indicated and helpful in avoiding
side effects like candida and fungi overgrowth which can cause digestive and elimination difficulties and other
side effects. Several probiotic products are widely available over-the-counter which combine these friendly
bacteria - live cultures of Lactobacillus acidophilous, Lactobacillus bifidus and other bacteria with FOS
(fructoologosaccharides) to promote growth in the gastrointestinal system. It's important to take this type of
supplement when taking antibiotics of any kind and best to be taken either 3-4 hours prior to, or after taking the
antibiotic dosage. Full live-cultured yogurt contains acidophilous and is a good food source for these friendly
bacteria. Also see Raintree's Amazon A-F.
Another common side effect when taking antibiotics is called a Herxheimer Reaction. This occurs from the
organism die-off and generally is the first indication that the antibiotic therapy is working. Symptoms that are
associated with a Herxheimer include: chills, fever, night sweats, muscle aches, joint pains, lymphatic pain, mental
fog, and extreme fatigue. Depending on the severity of the infection and resulting die-off, these symptoms can last
1-2 weeks and sometimes longer and can vary in intensity. Drinking at least two quarts of filtered or distilled
water every day to flush the organisms from the body is helpful in reducing the length and severity of a Herxheimer
reaction. Another natural remedy to reduce Herxheimer reactions and thought to be helpful in helping the lymph
glands to filter and remove dying organisms is a Whole Lemon-Olive Oil Drink. To prepare this natural remedy,
place one whole unpeeled lemon (washed) in a blender with 1 cup of juice or water and 1 tablespoon of extra
virgin olive oil. Blend in blender until smooth, then pour through a wire strainer. Discard pulp and drink liquid.
Once the mycoplasmas are being controlled by some form of effective natural or chemical antibiotic, re-nourishing
and replacing the nutrients drained from the infected host cells can help speed recovery and reduce symptoms.
A general multi-vitamin supplement plus extra C, D, E, CoQ-10, beta-carotene, quercetin, folic acid, bioflavoids
and biotin are necessary and helpful when recovering from a mycoplasmal infection.
Supplementing back the
depleted amino acids has been reported to be helpful in some recovering from these infections. These include L-cysteine, L-tyrosine, L-glutamine, L-carnitine, and malic acid. Remember, however, that mycoplasmas thrive on
arginine! Avoid L-arginine supplements and multi-amino acid formulas containing L-arginine, as well as foods
rich in arginine to avoid feeding the mycoplasmas. The richest food sources of arginine (to avoid) are nuts and
seeds, including the oils derived from seeds and nuts which should be eliminated or drastically reduced in the diet.
Vitamins A, C and E, and other antioxidants found in natural plants, have also been reported to help speed
recovery and to minimize the oxidative stress caused by mycoplasmas. One of the most popular antioxidants sold
today are various extracts of grape seeds. Remember however, most seeds are rich in arginine, including grape
seeds, and should generally be avoided.
Other helpful supplements to replenish drained nutrients from parasitic
mycoplasmas are generally indicated based upon which specific cells the mycoplasma might be feeding on and
which nutrients are being depleted. Specifically with fibromyalgia patients, leading research indicates that many
of the hormones and enzymes produced in the neuroendocrine system and Hypothalamus-Pituitary-Adrenal Axis
are depleted or malfunctioning which have the ability to cause many of the symptoms found in these patients.
Finally and most importantly is nutritionally supporting the immune system. There are various natural products
sold today which can stimulate and support immune function. There are many natural products available in the market place today which nutritionally support immune function. One of the best from the rainforest is cat's claw. Also see Raintree's Immune Support. Another important consideration is the elimination of drugs that might suppress immunity. Dr. Garth Nicolson,
one of the world renown experts on mycoplasmas states: "We have recommended that patients be taken off
antidepressants and other potentially immune-suppressing drugs. Some of these drugs are used to help alleviate
certain signs and symptoms, but in our opinion they can interfere with therapy, and they should be gradually
reduced or eliminated."(1) This of course would be indicated for many fibromyalgia and Chronic Fatigue patients
who are routinely prescribed antidepressants.
- Nicolson, et.al., Diagnosis and Integrative Treatment of Intracellular Bacterial Infections in Chronic Fatigue and Fibromyalgia
Syndromes, Gulf War Illness, Rheumatoid Arthritis and Other Chronic Illnesses. Clinical Practice of Alternative Medicine 2000; 1(2)
Testing for mycoplasmas is much harder and more complicated than testing for all other bacteria, which is one
of the main reasons conventional medical practitioners mis-diagnose or miss these types infections. The most
reliable testing method offered today is with a lab test called a PCR test (Polymerase Chain Reaction). Even
performing a PCR lab test on a standard whole blood sample may not find the mycoplasma, simply because the
mycoplasma may be residing in other fluids and tissues in the body and not the blood (i.e.; the fluid in the
joints, in the spinal fluid, or in any tissue cell like heart, liver, pancreas, endocrine organs, etc.). A PCR test is
generally performed by specific mycoplasma species. These laboratory tests can be expensive, but are
insurance reimburseable if ordered by your primary care physician. Specific mycoplasma PCR tests are
available through these companies, both of which have more information on mycoplasmas in general and testing at their websites:
|The Institute for Molecular Medicine
15162 Triton Lane
Huntington Beach, CA 92649
|Immunosciences Lab, Inc.
8730 Wilshire Blvd, Suite 305
Beverly Hill, CA 90211
The above text has been authored by Leslie Taylor, Milam County, Texas 77857 and copyrighted © 2001. All rights reserved. Please refer to the Copyright Statement on permitted uses of this document.
*The statements contained herein have not been evaluated
by the Food and Drug Administration. This information is provided for educational and entertainment use only. Nothing herein is intended to treat, cure, mitigate or prevent any disease.
Please refer to our Conditions of Use for this web site.
© Copyrighted 1996
to present by Leslie Taylor, Milam County, TX 77857.
All rights reserved. Please read the Conditions of Use, and Copyright Statement
for this web page and web site.
Last updated 12-21-2012